Duchenne
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients (NCT07287189) | Satellos Bioscience, Inc. | 2025-12-08 |
| Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping (NCT06244082) | Avidity Biosciences, Inc. | 2024-01-22 |
| Physical Therapy Treatment on Children and Adolescents With Neurological Pathologies (NCT05313295) | Universidad de Almeria | 2018-11-01 |
Track Duchenne automatically
Every clearance here is in the API, with alerts when new ones post.